Robert W.A. Sellers Edwards Lifesciences Corp (EW) insider trading activity

Robert W.A. Sellers is SVP, Corporate Controller of Edwards Lifesciences Corp. Currently has a direct ownership of 17,081 shares of EW, which is worth approximately $1.12 Million. The most recent transaction as insider was on May 11, 2024, when has been sold 229 shares (Common Stock) at a price of $86.72 per share, resulting in proceeds of $19,858. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K

0% 3M change

31.04% 12M change

Total Value Held $1.12 Million

ROBERT W.A. SELLERS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2024	SELL Payment of exercise price or tax liability	$19,858 $86.72 p/Share	229 Reduced 1.32%	17,081 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$15,146 $85.09 p/Share	178 Reduced 1.02%	17,310 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	2,445 Added 12.27%	17,488 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$10,230 $85.25 p/Share	120 Reduced 0.79%	15,043 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$9,016 $85.06 p/Share	106 Reduced 0.69%	15,163 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	1,998 Added 11.7%	15,085 Common Stock
Feb 12 2024	SELL Open market or private sale	$1,062,270 $87.0 p/Share	12,210 Reduced 48.27%	13,087 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	$448,717 $36.75 p/Share	12,210 Added 32.55%	25,297 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	1,800 Added 12.13%	13,035 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$14,287 $88.74 p/Share	161 Reduced 1.41%	11,235 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$11,891 $88.74 p/Share	134 Reduced 1.16%	11,396 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$10,219 $88.1 p/Share	116 Reduced 1.0%	11,530 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$9,044 $87.81 p/Share	103 Reduced 0.88%	11,646 Common Stock
Apr 28 2023	SELL Open market or private sale	$1,069,944 $87.2 p/Share	12,270 Reduced 51.08%	11,749 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	$431,904 $35.2 p/Share	12,270 Added 33.81%	24,019 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$20,241 $95.93 p/Share	211 Reduced 1.81%	11,436 Common Stock
May 08 2022	SELL Payment of exercise price or tax liability	$15,581 $100.52 p/Share	155 Reduced 1.31%	11,647 Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$13,470 $100.52 p/Share	134 Reduced 1.12%	11,802 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$12,288 $105.93 p/Share	116 Reduced 0.96%	11,936 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	1,180 Added 8.92%	12,052 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$18,256 $89.49 p/Share	204 Reduced 1.9%	10,555 Common Stock
May 11 2021	SELL Payment of exercise price or tax liability	$24,770 $90.4 p/Share	274 Reduced 2.48%	10,759 Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$12,203 $91.75 p/Share	133 Reduced 1.19%	11,033 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	1,340 Added 10.71%	11,166 Common Stock

RWS

Robert W.A. Sellers

SVP, Corporate Controller

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account